RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jaguar Health Stock

Jaguar Health P/E 2024

Jaguar Health P/E

-0.43

Ticker

JAGX

ISIN

US47010C4096

WKN

A2PLYX

As of Jul 31, 2024, Jaguar Health's P/E ratio was -0.43, a 34.38% change from the -0.32 P/E ratio recorded in the previous year.

The Jaguar Health P/E history

Jaguar Health Aktienanalyse

What does Jaguar Health do?

Jaguar Health Inc. is a biopharmaceutical company based in San Francisco, California, focused on the development and commercialization of innovative plant-based medicines. The company's history dates back to the founding of Napo Pharmaceuticals in 2002, which was renamed Jaguar Animal Health in 2007 to focus on the development of animal medicines. In 2015, Jaguar Health then established a subsidiary named Napo Pharmaceuticals to focus on the development of plant-based medicines for human use. Jaguar Health's business model is based on the research and development of medicines derived from plant extracts, particularly from the rainforest region in South America. The company collaborates with local communities and government agencies to ensure sustainable use of these plant resources. An important aspect of the business model is also cooperation and partnership with other companies and organizations to accelerate research and development and facilitate the market launch of new medicines. Jaguar Health is divided into different divisions that focus on specific medical applications. One important division is HIV/AIDS research, where the company is investigating various plant extracts that can alleviate symptoms of the disease and inhibit the spread of the virus. Another division is oncology research, in which Jaguar Health is working on the development of plant-based compounds that can inhibit the growth of tumor cells and improve the quality of life for cancer patients. A particular focus of Jaguar Health is also the research of plant-based medicines for the treatment of gastrointestinal diseases. The company has already developed the drug Mytesi based on the Croton lechleri tree, which is used to treat diarrhea in HIV/AIDS patients. Mytesi was approved by the US Food and Drug Administration (FDA) in 2016 and is the first drug developed by the company to market. Other products and medicines that Jaguar Health is working on include the drug Canalevia for the treatment of gastrointestinal inflammation in dogs and cats, as well as the drug Neonorm, which aims to improve intestinal mobility in foals and other animal species. Overall, Jaguar Health is working on a wide range of plant-based medicines and compounds for the treatment of various diseases and ailments. The company relies on close collaboration with government agencies, local communities, and other companies to accelerate the development and commercialization of innovative medicines while ensuring sustainable use of natural resources. Jaguar Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Jaguar Health's P/E Ratio

The Price to Earnings (P/E) Ratio of Jaguar Health is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Jaguar Health's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Jaguar Health is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Jaguar Health’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Jaguar Health stock

What is the price-to-earnings ratio of Jaguar Health?

The price-earnings ratio of Jaguar Health is currently -0.43.

How has the price-earnings ratio of Jaguar Health changed compared to last year?

The price-to-earnings ratio of Jaguar Health has increased by 34.38% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Jaguar Health high compared to other companies?

Yes, the price-to-earnings ratio of Jaguar Health is high compared to other companies.

How does an increase in the price-earnings ratio of Jaguar Health affect the company?

An increase in the price-earnings ratio of Jaguar Health would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Jaguar Health affect the company?

A decrease in the price-earnings ratio of Jaguar Health would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Jaguar Health?

Some factors that influence the price-earnings ratio of Jaguar Health are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Jaguar Health pay?

Over the past 12 months, Jaguar Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jaguar Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Jaguar Health?

The current dividend yield of Jaguar Health is .

When does Jaguar Health pay dividends?

Jaguar Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Jaguar Health?

Jaguar Health paid dividends every year for the past 0 years.

What is the dividend of Jaguar Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Jaguar Health located?

Jaguar Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jaguar Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jaguar Health from 7/31/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Jaguar Health pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Jaguar Health in the year 2023?

In the year 2023, Jaguar Health distributed 0 USD as dividends.

In which currency does Jaguar Health pay out the dividend?

The dividends of Jaguar Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Jaguar Health stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Jaguar Health

Our stock analysis for Jaguar Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jaguar Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.